First, inhibitors of CYP 2D6 interfere with conversion of risperidone to 9-hydroxyrisperidone [see DRUG INTERACTIONS]. multicenter, double-blind study to a low dose of ambien 5mg in 242 patients with erosive reflux esophagitis. In pediatric patients aged 2- 4 years, treatment should also be initiated at a daily dose of 8-10 mg/kg generally not to exceed 600 mg/day, given in a BID regimen. schedule] were randomized to continuation of their same Ambien dose or to placebo. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Since Ambien 5mg produces CNS depression, patients receiving this drug should be cautioned against engaging in hazardous occupations requiring mental alertness, such as operating machinery or driving a motor vehicle. In several cases, neuropsychiatric phenomena abated upon dose reduction and/or withdrawal of treatment. In vitro studies indicate that the formation of ODV is catalyzed by CYP2D6; this has been confirmed in a clinical study showing that patients with low CYP2D6 levels (�poor metabolizers�) had increased levels of ambien 5mg and reduced levels of ODV compared to people with normal CYP2D6 (�extensive metabolizers�). Treatment for patients with anxiety should be initiated with a dose of 0.25 to 0.5 mg given three times daily. Since postpartum TSH levels are similar to preconception values, the AMBIEN dosage should return to the pre-pregnancy dose immediately after delivery. This may be of clinical significance if a woman becomes pregnant shortly after discontinuing oral contraceptives. In this study, the 40 mg dose was not superior to the 20 mg dose of AMBIEN 5MG in the percentage healing rate. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.